This page shows you the latest news items in this category. This is page number 12.

Total 219673 results found since Jan 2013.

Red meat 'raises risk of breast cancer in women'
SWAPPING red meat for poultry could cut a woman's risk of developing breast cancer.
Source: Daily Express - Health - August 7, 2019 Category: Consumer Health News Source Type: news

Percutaneous vertebral augmentation in special Genant IV osteoporotic vertebral compression fractures
ConclusionDespite a great challenge, vertebral augmentation can be considered as a safe and effective option for treating special the Genant IV OVCF, showing significant restoration of vertebral body height, local kyphotic angle, and daily life function.
Source: Journal of Orthopaedic Translation - August 7, 2019 Category: Orthopaedics Source Type: research

Red Meat May Raise Breast Cancer Risk
WEDNESDAY, Aug. 7, 2019 -- Skipping that grilled T-bone and having chicken instead could reduce a woman ' s risk of breast cancer, a new study suggests. The World Health Organization has declared red meat a probable carcinogen, and this new study...
Source: Drugs.com - Daily MedNews - August 7, 2019 Category: General Medicine Source Type: news

Amentoflavone inhibits tumorsphere formation by regulating the Hedgehog/Gli1 signaling pathway in SUM159 breast cancer stem cells
This study aimed to investigate the effects of amentoflavone, a natural compound identified from Chamaecyparis obtusa, on stemness of basal-like SUM159 breast CSCs, and its underlying mechanism of action. We found that amentoflavone suppressed tumorsphere formation and regulated the expression of the stem cell markers CD44, CD24, and ALDH1 in a dose dependent manner, and inhibited Hedgehog (Hh) signaling by down-regulating Smo, Gli1, OCT4, and NANOG. Knock-down of Gli1 by siRNA significantly affected the expression of CD44, CD24, ALDH1, OCT4, and NANOG, and reduced tumorsphere formation efficiency in SUM159 breast CSCs. Ou...
Source: Journal of Functional Foods - August 7, 2019 Category: Nutrition Source Type: research

The retroclavicular approach to the PECS II (RAP) block: A novel regional technique for breast surgery.
Authors: Martin KM, Johnson B, Taylor RR PMID: 31378051 [PubMed - as supplied by publisher]
Source: Korean Journal of Anesthesiology - August 7, 2019 Category: Anesthesiology Tags: Korean J Anesthesiol Source Type: research

NICE approves drug with potential to prevent breast cancer return
An additional treatment option for people with a specific type of breast cancer has gained official approval with hopes it will help prevent the disease coming back.
Source: Nursing Times - August 7, 2019 Category: Nursing Source Type: news

Survivorship in young women after early breast cancer: a cross-sectional study of emotional traits along 3-years perspective.
CONCLUSIONS: Increased survival rate after breast cancer diagnosis is strongly linked to the management of emotional weakness of BC women because of modified living. Patients need to be supported to regain their life after clinical treatments though tailored psychological treatment along survivorship, not only in primary treatment. PMID: 31379381 [PubMed - in process]
Source: Rivista di Psichiatria - August 7, 2019 Category: Psychiatry Tags: Riv Psichiatr Source Type: research

PCDHGB7 Increases Chemosensitivity to Carboplatin by Inhibiting HSPA9 via Inducing Apoptosis in Breast Cancer.
In this study, we examined the effects of PCDHGB7 on the sensitivity of TNBC cells to carboplatin and investigated the underlying mechanism. By knocking down and overexpressing PCDHGB7 in HS578T and BT549 cells, we confirmed that PCDHGB7 increases TNBC cell chemosensitivity to carboplatin. Mechanistically, we found that PCDHGB7 negatively regulates the expression of HSPA9, uplifting its inhibition on P53 translocation and caspase-3 activation. Thus, we demonstrated that PCDHGB7 increases chemosensitivity of TNBC cells to carboplatin by inhibiting HSPA9 via inducing apoptosis. PCDHGB7 and HSPA9 represent potential therapeut...
Source: Disease Markers - August 7, 2019 Category: Laboratory Medicine Tags: Dis Markers Source Type: research

Olivia Newton-John reveals breast cancer return - how is the disease treated?
BREAST cancer is the most common type of cancer in the UK and around one in eight woman are diagnosed with the disease during their lifetime. Olivia Newton-John has been battling the disease on and off for years, and recently announced it had returned. What are the symptoms to look out for and what is the latest treatment to help keep breast cancer at bay?
Source: Daily Express - Health - August 7, 2019 Category: Consumer Health News Source Type: news

Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype.
Authors: Giuli MV, Giuliani E, Screpanti I, Bellavia D, Checquolo S Abstract Triple-negative breast cancer (TNBC) is a subgroup of 15%-20% of diagnosed breast cancer patients. It is generally considered to be the most difficult breast cancer subtype to deal with, due to the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), which usually direct targeted therapies. In this scenario, the current treatments of TNBC-affected patients rely on tumor excision and conventional chemotherapy. As a result, the prognosis is overall poor. Thus, the identification and...
Source: Journal of Oncology - August 7, 2019 Category: Cancer & Oncology Tags: J Oncol Source Type: research

A Review of the Hereditary Component of Triple Negative Breast Cancer: High- and Moderate-Penetrance Breast Cancer Genes, Low-Penetrance Loci, and the Role of Nontraditional Genetic Elements.
Authors: Ellsworth DL, Turner CE, Ellsworth RE Abstract Triple negative breast cancer (TNBC), representing 10-15% of breast tumors diagnosed each year, is a clinically defined subtype of breast cancer associated with poor prognosis. The higher incidence of TNBC in certain populations such as young women and/or women of African ancestry and a unique pathological phenotype shared between TNBC and BRCA1-deficient tumors suggest that TNBC may be inherited through germline mutations. In this article, we describe genes and genetic elements, beyond BRCA1 and BRCA2, which have been associated with increased risk of TNBC. M...
Source: Journal of Oncology - August 7, 2019 Category: Cancer & Oncology Tags: J Oncol Source Type: research

Downregulation of GATS gene inhibits proliferation, clonogenicity and migration in triple negative breast cancer cells MDA-MB-231 by cell autophagy.
Authors: Feng F, Zhang D, Han F, Zhang X, Duan T, Zhang X Abstract The triple negative breast cancer (TNBC) accounts for 15% to 20% of the total number of breast cancer diagnosed. A number of clinical studies have shown that TNBC has a high risk of early recurrence and distant metastasis, and a low rate of disease free survival and total survival. The premise of TNBC deterioration was abnormal proliferation and migration of tumor cells, and this study firstly showed that GATS gene could promote proliferation of MDA-MB-231 breast cancer cells. Through lentiviral expression system, the GATS gene was konckdown by shGA...
Source: Cancer Biomarkers - August 7, 2019 Category: Cancer & Oncology Tags: Cancer Biomark Source Type: research

GSE135427 Identification of the KDM4B regulated transcriptome in the ER positive breast cancer cell line MCF-7
Contributors : Mark A Wade ; Dominic Jones ; Laura Wilson ; Huw Thomas ; Luke GaughanSeries Type : Expression profiling by arrayOrganism : Homo sapiensTo elucidate the KDM4B regulated transcriptomes in ER-positive breast cancer cells we assessed global gene expression changes in KDM4B-depleted MCF-7 cells by microarray analysis using the Illumina Human HT12 Version 4 BeadChip array. Differentially expressed genes were compared with KDM3A and FOXA1 regulated transcriptomes. We identified 229 genes co-regulated by all three enzymes and that co-regulated genes were involved in cell cycle processes. We identified that 53% and ...
Source: GEO: Gene Expression Omnibus - August 7, 2019 Category: Genetics & Stem Cells Tags: Expression profiling by array Homo sapiens Source Type: research

LINC00309 is associated with short disease-free survival in breast cancer
Long non-coding RNAs play an important role in breast cancer. Even with adjuvant hormone therapy, patients with estrogen receptor positive breast cancer can present with recurrences and distant metastases. We ...
Source: Cancer Cell International - August 7, 2019 Category: Cancer & Oncology Authors: Sheng Huang, Yayun Chi, Weiru Chi, Rong Guo, Yonghui Su, Jingyan Xue, Shaoqiang Zhou, Jiankui Wang, Zhuangqing Yang, Jianyun Nie, Zhimin Shao, Dedian Chen and Jiong Wu Tags: Primary research Source Type: research

Research Articles Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
Longitudinal analysis of circulating tumor DNA (ctDNA) has shown promise for monitoring treatment response. However, most current methods lack adequate sensitivity for residual disease detection during or after completion of treatment in patients with nonmetastatic cancer. To address this gap and to improve sensitivity for minute quantities of residual tumor DNA in plasma, we have developed targeted digital sequencing (TARDIS) for multiplexed analysis of patient-specific cancer mutations. In reference samples, by simultaneously analyzing 8 to 16 known mutations, TARDIS achieved 91 and 53% sensitivity at mutant allele fract...
Source: Science Translational Medicine - August 7, 2019 Category: Biomedical Science Authors: McDonald, B. R., Contente-Cuomo, T., Sammut, S.-J., Odenheimer-Bergman, A., Ernst, B., Perdigones, N., Chin, S.-F., Farooq, M., Mejia, R., Cronin, P. A., Anderson, K. S., Kosiorek, H. E., Northfelt, D. W., McCullough, A. E., Patel, B. K., Weitzel, J. N., Tags: Research Articles Source Type: research

Cancers, Vol. 11, Pages 1128: CSCs in Breast Cancer —One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs
Cancers, Vol. 11, Pages 1128: CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs Cancers doi: 10.3390/cancers11081128 Authors: Andrew Sulaiman Sarah McGarry Xianghui Han Sheng Liu Lisheng Wang Unlike other breast cancer subtypes, triple-negative breast cancer (TNBC) has no specific targets and is characterized as one of the most aggressive subtypes of breast cancer that disproportionately accounts for the majority of breast cancer-related deaths. Current conventional chemotherapeutics target the bulk tumor population, but not th...
Source: Cancers - August 7, 2019 Category: Cancer & Oncology Authors: Andrew Sulaiman Sarah McGarry Xianghui Han Sheng Liu Lisheng Wang Tags: Review Source Type: research

Cancers, Vol. 11, Pages 1126: The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
maswamy The hedgehog (Hh) pathway plays a key role in embryonic development and stem cell programs. Deregulation of the Hh pathway is a key driver of basal cell carcinoma, and therapeutic targeting led to approval of Hh inhibitor, vismodegib, in the management of this cancer. The Hh pathway is implicated in other malignancies including hormone receptor (HR+) positive and triple negative breast cancer (TNBC). Hh signaling, which is activated in human mammary stem cells, results in activation of glioma-associated oncogene (GLI) transcription factors. High GLI1 expression correlates with worse outcomes in breast cancer. N...
Source: Cancers - August 7, 2019 Category: Cancer & Oncology Authors: Priyanka Bhateja Mathew Cherian Sarmila Majumder Bhuvaneswari Ramaswamy Tags: Review Source Type: research

Enhanced Deep-Learning Prediction of Molecular Properties via Augmentation of Bond Topology.
Abstract Deep learning has made great strides in tackling chemical problems, but still lacks full-fledged representations for three-dimensional (3D) molecular structures for its inner working. For example, the molecular graph, commonly used in chemistry and recently adapted to the graph convolutional network (GCN), is inherently a 2D representation of 3D molecules. Herein we propose an advanced version of the GCN, called 3DGCN, which receives the 3D molecular information from a molecular graph augmented by the information on the bond direction. While outperforming the state-of-the art deep-learning models in the p...
Source: ChemMedChem - August 7, 2019 Category: Chemistry Authors: Cho H, Choi IS Tags: ChemMedChem Source Type: research

Psychometric Properties of the Short Form of the Fear of Cancer Recurrence Inventory (FCRI) in Chinese Breast Cancer Survivors
Objective: Currently, fear of cancer recurrence (FCR) is emerging as an important issue for long-term breast cancer survivors and is associated with lower quality of life and functional impairment. Given that there is a dearth of research regarding the FCR of Chinese breast cancer survivors, this study investigated whether the short form of the Fear of Cancer Recurrence Inventory (FCRI) could detect high FCR and explored the level and characteristics of FCR in breast cancer survivors. Methods: Two hundred forty patients who had undergone successful breast cancer surgery in China submitted their survey through a website. T...
Source: Frontiers in Psychiatry - August 7, 2019 Category: Psychiatry Source Type: research

Carbonic anhydrase inhibitors based on sorafenib scaffold: Design, synthesis, crystallographic investigation and effects on primary breast cancer cells.
Abstract Carbonic anhydrase inhibitors (CAIs) of the sulfonamide, sulfamate and coumarin classes bearing the phenylureido tail found in the clinically used drug Sorafenib, a multikinase inhibitor actually used for the management of hepatocellular carcinomas, are reported. All compounds were assayed on human (h) CA isoforms I, II, VII and IX, involved in various pathologies. Among the sulfonamides, several compounds were selective for inhibiting hCA IX, with KI values in the low nanomolar ranges (i.e. 0.7-30.2 nM). We explored the binding modes of such compounds by means of X-ray crystallographic studies on isofo...
Source: European Journal of Medicinal Chemistry - August 7, 2019 Category: Chemistry Authors: Bozdag M, Ferraroni M, Ward C, Carta F, Bua S, Angeli A, Langdon SP, Kunkler IH, Al-Tamimi AS, Supuran CT Tags: Eur J Med Chem Source Type: research

The Experience of Chemotherapy Teaching and Readability of Chemotherapy Educational Materials for Women with Breast Cancer
AbstractChemotherapy is one of the most common forms of treatment for women with breast cancer. While chemotherapy is often effective, managing side effects can be challenging. Chemotherapy education is critical in assisting patients to manage side effects and to improve the treatment experience. However, materials are often not thoroughly assessed for readability and format which could be problematic for patients learning self-care while in treatment. We used a mixed-method design to illuminate chemotherapy teaching and focused on readability and format of education materials. We scored the materials using three readabili...
Source: Journal of Cancer Education - August 7, 2019 Category: Cancer & Oncology Source Type: research

Effects of Exercise on Chemotherapy Completion and Hospitalization Rates: The OptiTrain Breast Cancer Trial.
CONCLUSION: No beneficial effects of either RT-HIIT or AT-HIIT on chemotherapy completion rates were found. However, combined resistance training and high-intensity interval training were effective to reduce hospitalization rates, and both exercise groups had a positive effect on thrombocytopenia. These are important findings with potential positive implications for the health of women with breast cancer and costs associated with treatment-related complications. IMPLICATIONS FOR PRACTICE: Completing the prescribed chemotherapy regimen is strongly associated with a good prognosis for patients with primary breast cancer...
Source: The Oncologist - August 7, 2019 Category: Cancer & Oncology Authors: Mijwel S, Bolam KA, Gerrevall J, Foukakis T, Wengström Y, Rundqvist H Tags: Oncologist Source Type: research

Silencing of the cytokine receptor TNFRSF13B: A new therapeutic target for triple-negative breast cancer.
CONCLUSION: TACI silencing can be a new and promising therapeutic target for mesenchymal-stem like triple-negative breast cancer subtype. PMID: 31400636 [PubMed - as supplied by publisher]
Source: Cytokine - August 7, 2019 Category: Molecular Biology Authors: Abo-Elfadl MT, Gamal-Eldeen AM, Ismail MF, Shahin NN Tags: Cytokine Source Type: research

Transfer of Candesartan Into Human Breast Milk.
CONCLUSION: A relative infant dose of 0.09% suggests that maternal benefit from candesartan at standard therapeutic doses may outweigh risk in breastfeeding healthy, term infants. PMID: 31403599 [PubMed - as supplied by publisher]
Source: Obstetrics and Gynecology - August 7, 2019 Category: OBGYN Authors: Coberger ED, Jensen BP, Dalrymple JM Tags: Obstet Gynecol Source Type: research

Inflammation and breast density among female Chinese immigrants: exploring variations across neighborhoods
ConclusionsAmong Chinese immigrant women, aggregate analyses that do not take neighborhood context into consideration can mask potential variations in association of inflammatory markers with breast density. Future studies should consider how neighborhood contextual factors may contribute to differential risk pathways.
Source: Cancer Causes and Control - August 7, 2019 Category: Cancer & Oncology Source Type: research

Approval for treatment option for early breast cancer
NICE recommends neratinib in draft guidance Related items fromOnMedica NICE rejects adjuvant use of breast cancer drug Red tape delaying availability of new cancer drugs One in 10 children in phase I cancer trials respond to drugs Is crowdfunding for cancer patients paying for ‘quackery’? Cancer patients using complementary meds die sooner
Source: OnMedica Latest News - August 7, 2019 Category: UK Health Source Type: news

A Value of Information Analysis of Research on the 21-Gene Assay for Breast Cancer Management
The 21-gene assay Oncotype DX (21-GA) shows promise as a guide in deciding when to initiate adjuvant chemotherapy in women with hormone receptor –positive early-stage breast cancer. Nevertheless, its routine use remains controversial, owing to insufficient evidence of its clinical utility and cost-effectiveness. Accordingly, we aim to quantify the value of conducting further research to reduce decision uncertainty in the use of the 21-GA.
Source: Value in Health - August 7, 2019 Category: International Medicine & Public Health Authors: Natalia R. Kunst, Fernando Alarid-Escudero, A. David Paltiel, Shi-Yi Wang Source Type: research

Automatic Planning of Whole Breast Radiation Therapy Using Machine Learning Models
Conclusions: We developed an automatic treatment planning system that generates WBRT plans with optimal energy selection, clinically comparable plan quality, and significant reduction in planning time, allowing for near-real-time planning.
Source: Frontiers in Oncology - August 7, 2019 Category: Cancer & Oncology Source Type: research

6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers.
Conclusions: PFKFB2 is a novel target whose inhibition can enhance the effect of paclitaxel-based primary chemotherapy upon ovarian and breast cancers retaining wtTP53. PMID: 31391192 [PubMed - as supplied by publisher]
Source: Clinical Cancer Research - August 7, 2019 Category: Cancer & Oncology Authors: Yang H, Shu Z, Jiang Y, Mao W, Pang L, Redwood A, Jeter-Jones SL, Jennings NB, Ornelas A, Zhou J, Rodriguez-Aguayo C, Bartholomeusz G, Iles LR, Zacharias NM, Millward SW, Lopez-Berestein G, Le XF, Ahmed AA, Piwnica-Worms H, Sood AK, Bast RC, Lu Z Tags: Clin Cancer Res Source Type: research

Differential Diagnosis of Epithelioid Malignant Mesothelioma With Lung and Breast Pleural Metastasis: A Systematic Review Compared With a Standardized Panel of Antibodies-A New Proposal That May Influence Pathologic Practice.
CONCLUSIONS.—: Highlighted by their relevance in the large cohort reported, we recommend 2 useful panels to the differential diagnosis at 10% cutoff. PMID: 31389715 [PubMed - as supplied by publisher]
Source: Archives of Pathology and Laboratory Medicine - August 7, 2019 Category: Laboratory Medicine Authors: Le Stang N, Burke L, Blaizot G, Gibbs AR, Lebailly P, Clin B, Girard N, Galateau-Sallé F, MESOPATH and EURACAN networks Tags: Arch Pathol Lab Med Source Type: research

Personalised breast cancer test could tell when to stop treatment
A blood test for a person ’s specific breast cancer mutations – which is 100 times more sensitive than existing tests – seems to tell when treatment is working and when more is needed
Source: New Scientist - Health - August 7, 2019 Category: Consumer Health News Source Type: research

A case series of breast reconstruction for amastia in a family with ectodermic dysplasia
We described in this article a series of three female patients issue from the same family.
Source: Journal of Plastic, Reconstructive and Aesthetic Surgery - August 7, 2019 Category: Cosmetic Surgery Authors: J LALOZE, B CHAPUT, J USSEGLIO-GROSSO, JL GROLLEAU, C PIENKOWSKI, T MERESSE Tags: Correspondence and Communications Source Type: research

Novel treatment for mild and moderate VPI using implantable AlloDerm for posterior pharyngeal wall augmentation: Case series and review of surgical techniques
ConclusionUltimately, implantable AlloDerm for posterior pharyngeal wall augmentation is a useful, low risk method for treating mild to moderate velopharyngeal insufficiency.
Source: American Journal of Otolaryngology - August 6, 2019 Category: Endocrinology Source Type: research

Novel Olive Oil Phenolic (-)-Oleocanthal (+)-Xylitol-Based Solid Dispersion Formulations with Potent Oral Anti-Breast Cancer Activities
Publication date: Available online 5 August 2019Source: International Journal of PharmaceuticsAuthor(s): Mohammed H. Qusa, Abu Bakar Siddique, Sami Nazzal, Khalid A. El SayedAbstractEpidemiological studies have compellingly documented the ability of the Mediterranean diet rich in extra-virgin olive oil to reduce the incidence of certain malignancies, and cardiovascular diseases, and slow the Alzheimer’s disease progression. S-(-)-Oleocanthal (OC) was identified as the most bioactive olive oil phenolics with documented anti-inflammatory, anticancer, and anti-Alzheimer’s activities. OC consumption causes irritating sensa...
Source: International Journal of Pharmaceutics - August 6, 2019 Category: Drugs & Pharmacology Source Type: research

Early Cardiac Damage Detection With CMR in Women With Breast Cancer.
Conditions:   Cardiotoxicity;   Breast Cancer;   Chemotherapy Induced Systolic Dysfunction Intervention:   Diagnostic Test: CMR Sponsor:   Radboud University Not yet recruiting
Source: ClinicalTrials.gov - August 6, 2019 Category: Research Source Type: clinical trials

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ
Condition:   Breast Ductal Carcinoma in Situ Interventions:   Drug: Low-dose tamoxifen;   Radiation: Whole breast radiotherapy Sponsors:   National Taiwan University Hospital;   Tri-Service General Hospital;   Koo Foundation Sun Yat-Sen Cancer Center;   Kaohsiung Medical University;   Kyoto University;   Mackay Memorial Hospital Recruiting
Source: ClinicalTrials.gov - August 6, 2019 Category: Research Source Type: clinical trials

Early Cardiac Damage Detection With CMR in Women With Breast Cancer.
Conditions:   Cardiotoxicity;   Breast Cancer;   Chemotherapy Induced Systolic Dysfunction Intervention:   Diagnostic Test: CMR Sponsor:   Radboud University Not yet recruiting
Source: ClinicalTrials.gov - August 6, 2019 Category: Research Source Type: clinical trials

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ
Condition:   Breast Ductal Carcinoma in Situ Interventions:   Drug: Low-dose tamoxifen;   Radiation: Whole breast radiotherapy Sponsors:   National Taiwan University Hospital;   Tri-Service General Hospital;   Koo Foundation Sun Yat-Sen Cancer Center;   Kaohsiung Medical University;   Kyoto University;   Mackay Memorial Hospital Recruiting
Source: ClinicalTrials.gov - August 6, 2019 Category: Research Source Type: clinical trials

Early Cardiac Damage Detection With CMR in Women With Breast Cancer.
Conditions:   Cardiotoxicity;   Breast Cancer;   Chemotherapy Induced Systolic Dysfunction Intervention:   Diagnostic Test: CMR Sponsor:   Radboud University Not yet recruiting
Source: ClinicalTrials.gov - August 6, 2019 Category: Research Source Type: clinical trials

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ
Condition:   Breast Ductal Carcinoma in Situ Interventions:   Drug: Low-dose tamoxifen;   Radiation: Whole breast radiotherapy Sponsors:   National Taiwan University Hospital;   Tri-Service General Hospital;   Koo Foundation Sun Yat-Sen Cancer Center;   Kaohsiung Medical University;   Kyoto University;   Mackay Memorial Hospital Recruiting
Source: ClinicalTrials.gov - August 6, 2019 Category: Research Source Type: clinical trials

Early Cardiac Damage Detection With CMR in Women With Breast Cancer.
Conditions:   Cardiotoxicity;   Breast Cancer;   Chemotherapy Induced Systolic Dysfunction Intervention:   Diagnostic Test: CMR Sponsor:   Radboud University Not yet recruiting
Source: ClinicalTrials.gov - August 6, 2019 Category: Research Source Type: clinical trials

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ
Condition:   Breast Ductal Carcinoma in Situ Interventions:   Drug: Low-dose tamoxifen;   Radiation: Whole breast radiotherapy Sponsors:   National Taiwan University Hospital;   Tri-Service General Hospital;   Koo Foundation Sun Yat-Sen Cancer Center;   Kaohsiung Medical University;   Kyoto University;   Mackay Memorial Hospital Recruiting
Source: ClinicalTrials.gov - August 6, 2019 Category: Research Source Type: clinical trials

Early Cardiac Damage Detection With CMR in Women With Breast Cancer.
Conditions:   Cardiotoxicity;   Breast Cancer;   Chemotherapy Induced Systolic Dysfunction Intervention:   Diagnostic Test: CMR Sponsor:   Radboud University Not yet recruiting
Source: ClinicalTrials.gov - August 6, 2019 Category: Research Source Type: clinical trials

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ
Condition:   Breast Ductal Carcinoma in Situ Interventions:   Drug: Low-dose tamoxifen;   Radiation: Whole breast radiotherapy Sponsors:   National Taiwan University Hospital;   Tri-Service General Hospital;   Koo Foundation Sun Yat-Sen Cancer Center;   Kaohsiung Medical University;   Kyoto University;   Mackay Memorial Hospital Recruiting
Source: ClinicalTrials.gov - August 6, 2019 Category: Research Source Type: clinical trials